| Mr Chester Kenneth Guss, RN, APN | |
|
150 Bergen St, Newark, NJ 07103-2496 | |
| (973) 972-9872 | |
| Not Available |
| Full Name | Mr Chester Kenneth Guss |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 150 Bergen St, Newark, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164180386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR15134100 (New Jersey) | Secondary |
| 363LA2100X | Nurse Practitioner - Acute Care | 26NJ01236100 (New Jersey) | Primary |
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
The beginning of October marks the start of Talk About Prescriptions Month, which is sponsored by the National Council on Patient Information and Education. In support of this annual awareness effort, Health Net, Inc. (NYSE:HNT) is sharing tips to help consumers safely take over-the-counter (OTC) and prescription medications.
Australian researchers have led a study published in the New England Journal of Medicine that shows a simple blood test can allow doctors to predict which HIV patients will have a side effect, known as a hypersensitivity reaction, to a particular medication before it is prescribed.
BioCision, LLC, a leader in advanced technology to improve biological sample handling and standardization, today announced that it will collaborate with Celgene Cellular Therapeutics (CCT) (a subsidiary of Celgene Corporation), to accelerate the development of a cell thawing solution based on BioCision's proprietary ThawSTARÔ technology for the 6 mL injectable vial that CCT has chosen to store PDA-002, a cryopreserved, allogeneic cell therapy currently in clinical development to treat diabetic foot ulcers in patients with peripheral arterial disease.
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that they have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Chester Kenneth Guss, RN, APN 7 Fischer Trl, Denville, NJ 07834-1121 Ph: (973) 476-6586 | Mr Chester Kenneth Guss, RN, APN 150 Bergen St, Newark, NJ 07103-2496 Ph: (973) 972-9872 |
News Archive
The beginning of October marks the start of Talk About Prescriptions Month, which is sponsored by the National Council on Patient Information and Education. In support of this annual awareness effort, Health Net, Inc. (NYSE:HNT) is sharing tips to help consumers safely take over-the-counter (OTC) and prescription medications.
Australian researchers have led a study published in the New England Journal of Medicine that shows a simple blood test can allow doctors to predict which HIV patients will have a side effect, known as a hypersensitivity reaction, to a particular medication before it is prescribed.
BioCision, LLC, a leader in advanced technology to improve biological sample handling and standardization, today announced that it will collaborate with Celgene Cellular Therapeutics (CCT) (a subsidiary of Celgene Corporation), to accelerate the development of a cell thawing solution based on BioCision's proprietary ThawSTARÔ technology for the 6 mL injectable vial that CCT has chosen to store PDA-002, a cryopreserved, allogeneic cell therapy currently in clinical development to treat diabetic foot ulcers in patients with peripheral arterial disease.
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that they have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies.
› Verified 9 days ago
Mr. Michael C Cadorette, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Gateway Ctr Ste 2600, Newark, NJ 07102 Phone: 866-949-0108 | |
Casey Yeonjoo Cho, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-6938 | |
Mrs. Kisha Tamara Anderson, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 151 Washington St, Newark, NJ 07102 Phone: 973-622-3900 Fax: 973-622-1698 | |
Sabitri Nesbitt, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 151 Washington St, Newark, NJ 07102 Phone: 973-622-3900 Fax: 973-622-1698 | |
Marva Monique, Natasha Barbour, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 394 University Ave, Newark, NJ 07102 Phone: 973-877-6171 | |
Francois Joseph Nguetsop, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 394 University Ave, Newark, NJ 07102 Phone: 973-204-6545 | |
Debra J Brouwer, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-7000 |